301033 迈普医学
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)8.1296.6016.1109.84611.643
总资产报酬率 ROA (%)6.8965.3374.8127.4859.383
投入资产回报率 ROIC (%)7.7915.9445.2438.35610.780

边际利润分析
销售毛利率 (%)78.21982.00684.00682.38683.481
营业利润率 (%)33.00320.90721.17628.42532.031
息税前利润/营业总收入 (%)32.60921.03120.41633.99734.981
净利润/营业总收入 (%)27.65417.70618.30229.05529.841

收益指标分析
经营活动净收益/利润总额(%)81.98685.95364.80251.31760.182
价值变动净收益/利润总额(%)4.5597.68419.98213.71412.308
营业外收支净额/利润总额(%)-0.523-0.511-3.46515.2838.004

偿债能力分析
流动比率 (X)6.3363.9592.9147.6994.491
速动比率 (X)5.5513.5752.5547.3084.197
资产负债率 (%)10.90819.20219.10822.8870.242
带息债务/全部投入资本 (%)-5.0502.50510.63214.06211.966
股东权益/带息债务 (%)-1,972.8053,680.851826.510595.461725.819
股东权益/负债合计 (%)816.799420.789423.348334.818310.246
利息保障倍数 (X)-146.88491.336-398.06876.614214.493

营运能力分析
应收账款周转天数 (天)20.98022.21614.50715.29217.550
存货周转天数 (天)199.953240.943291.585250.574286.410